2Seventy Bio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $2,926 | $13,534 | $8,967 | $12,435 |
Gross Profit | -5,917 | 7,766 | 5,514 | 5,829 |
EBITDA | -21,439 | -11,780 | -18,249 | -46,547 |
EBIT | -23,094 | -13,438 | -19,925 | -48,654 |
Net Income | -19,520 | -9,933 | 24,879 | -52,673 |
Net Change In Cash | 2,926 | 13,534 | 8,967 | 12,435 |
Free Cash Flow | -9,474 | -10,539 | -23,203 | -42,489 |
Cash | 71,244 | 59,984 | 111,864 | 56,792 |
Basic Shares | 52,334 | 52,263 | 55,011 | 52,071 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $37,862 | $100,387 | $91,496 | $54,522 |
Gross Profit | 37,862 | 83,469 | 65,277 | 52,005 |
EBITDA | -98,446 | -206,418 | -251,143 | 16,057 |
EBIT | -105,542 | -216,703 | -262,908 | -292,213 |
Net Income | -57,247 | -217,570 | -254,144 | -292,213 |
Net Change In Cash | 37,862 | 100,387 | 91,496 | 54,522 |
Cost of Revenue | -59,208 | 163,266 | ||
Free Cash Flow | -85,705 | -180,723 | -259,976 | -226,609 |
Cash | 71,244 | 74,958 | 71,032 | 130,414 |
Basic Shares | 52,218 | 49,276 | 35,637 | 23,585 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.30 |
2024-09-30 | -$0.19 |
2024-06-30 | $0.45 |
2024-03-31 | -$1.01 |
